PRESS RELEASE published on 11/02/2023 at 11:30, 1 year ago Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 10/30/2023 at 08:00, 1 year ago CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission
PRESS RELEASE published on 10/26/2023 at 20:45, 1 year ago Moderna Named a Top Employer by Science for Ninth Consecutive Year
PRESS RELEASE published on 10/24/2023 at 13:00, 1 year ago Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19
PRESS RELEASE published on 10/19/2023 at 13:45, 1 year 1 month ago Moderna to Host Second Digital Investor Event on November 8th, 2023
PRESS RELEASE published on 10/12/2023 at 13:00, 1 year 1 month ago Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
PRESS RELEASE published on 10/04/2023 at 13:00, 1 year 1 month ago Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
PRESS RELEASE published on 09/30/2023 at 01:37, 1 year 1 month ago Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/14/2023 at 16:15, 1 year 2 months ago EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
PRESS RELEASE published on 09/13/2023 at 12:30, 1 year 2 months ago Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
Published on 11/22/2024 at 00:00, 9 hours 2 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 10 hours 57 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 11 hours 12 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 12 hours 47 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 12 hours 52 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/22/2024 at 08:30, 32 minutes ago Poland as an interesting development direction for German B2C e-commerce companies?
Published on 11/22/2024 at 08:12, 50 minutes ago EQS-Adhoc: PVA TePla AG launches share buyback program to support strategic acquisitions and long-term compensation plans
Published on 11/22/2024 at 08:00, 1 hour 1 minute ago Addition of Mr Alain Nydegger as an Eligible Participant under the Group’s Matching Share Plan 2025-2028
Published on 11/21/2024 at 06:58, 1 day 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 1 hour ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
